45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
3,040
Insurances with rates
141
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| RX-137245 | NUSINERSEN (PF) 12 MG/5 ML INTRATHECAL SOLUTION | $455,356 | $455,356 | — | — | 112 |
| RX-203302 | VUTRISIRAN 25 MG/0.5 ML SUBCUTANEOUS SYRINGE | $272,037 | $272,037 | — | — | 112 |
| RX-211159 | OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23,000 UNIT/23 ML SUBCUT SOLN | $130,286 | $130,286 | — | — | 109 |
| RX-204671 | TREMELIMUMAB-ACTL 20 MG/ML INTRAVENOUS SOLUTION | $127,265 | $127,265 | — | — | 224 |
| RX-500112 | IPILIMUMAB 5 MG/ML INTRAVENOUS SOLUTION (WRAPPER) | $110,830 | $110,830 | — | — | 224 |
| RX-202017 | TEBENTAFUSP-TEBN 100 MCG/0.5 ML INTRAVENOUS SOLUTION | $107,550 | $107,550 | — | — | 112 |
| RX-107664 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION | $95,365 | $95,365 | — | — | 112 |
| RX-202466 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION | $94,383 | $94,383 | — | — | 112 |
| RX-127653 | ALEMTUZUMAB 12 MG/1.2 ML INTRAVENOUS SOLUTION | $89,233 | $89,233 | — | — | 112 |
| RX-131323 | TALIMOGENE LAHERPAREPVEC 10EXP8 (100 MILLION)PFU/ML SUSP FOR INJECTION | $88,021 | $88,021 | — | — | 112 |
| RX-199684 | LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION | $87,089 | $87,089 | — | — | 112 |
| RX-192695 | CALASPARGASE PEGOL-MKNL 750 UNIT/ML INTRAVENOUS SOLUTION | $77,352 | $77,352 | — | — | 29 |
| RX-146166 | INOTUZUMAB OZOGAMICIN 0.9 MG(0.25 MG/ML INITIAL CONCENTRATION) IV SOLN | $73,183 | $73,183 | — | — | 112 |
| PX-36163685001 | HC Insertion/Replacement Spine Neurostim Pulse Generator or Receiver Require Pocket Creation & Cnct | $66,147 | $42,996 | — | — | 29 |
| RX-137896 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $65,143 | $65,143 | — | — | 32 |
| RX-190594 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION | $59,184 | $59,184 | — | — | 112 |
| RX-207058 | ROZANOLIXIZUMAB-NOLI 140 MG/ML SUBCUTANEOUS SOLUTION | $56,797 | $56,797 | — | — | 112 |
| RX-187815 | TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE | $53,884 | $53,884 | — | — | 32 |
| RX-206664 | EPCORITAMAB-BYSP 48 MG/0.8 ML SUBCUTANEOUS SOLUTION | $50,430 | $50,430 | — | — | 112 |
| RX-207040 | EFGARTIGIMOD ALFA 1008 MG-HYALURON-QVFC 11,200 UNIT/5.6 ML SUBCUT SOLN | $49,231 | $49,231 | — | — | 112 |
| RX-208617 | TORIPALIMAB-TPZI 240 MG/6 ML (40 MG/ML) INTRAVENOUS SOLUTION | $48,786 | $48,786 | — | — | 96 |
| RX-210073 | TARLATAMAB-DLLE 10 MG INTRAVENOUS SOLUTION | $46,350 | $46,350 | — | — | 109 |
| RX-206087 | RETIFANLIMAB-DLWR 500 MG/20 ML INTRAVENOUS SOLUTION | $45,114 | $45,114 | — | — | 112 |
| RX-105644 | CABAZITAXEL 10 MG/ML (FIRST DILUTION) INTRAVENOUS SOLUTION | $44,160 | $44,160 | — | — | 5 |
| RX-196883 | PERTUZUMAB 1,200 MG-TRASTUZUMAB 600 MG-HYALURON-ZZXF/15 ML SUBCUT SOLN | $43,628 | $43,628 | — | — | 112 |
| RX-201759 | SIROLIMUS-PROTEIN BOUND 100 MG INTRAVENOUS SUSPENSION | $42,939 | $42,939 | — | — | 96 |
| RX-207693 | ELRANATAMAB-BCMM 40 MG/ML SUBCUTANEOUS SOLUTION | $42,858 | $42,858 | — | — | 218 |
| RX-111348 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION | $39,511 | $39,511 | — | — | 112 |
| RX-193445 | LUSPATERCEPT-AAMT 75 MG SUBCUTANEOUS SOLUTION | $37,759 | $37,759 | — | — | 112 |
| RX-110751 | LEUPROLIDE ACETATE (6 MONTH) 45 MG INTRAMUSCULAR SYRINGE KIT | $37,312 | $37,312 | — | — | 112 |
| RX-199692 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION | $36,813 | $36,813 | — | — | 112 |
| RX-207664 | TALQUETAMAB-TGVS 40 MG/ML SUBCUTANEOUS SOLUTION | $35,942 | $35,942 | — | — | 109 |
| PX-36162362001 | HC Implantation/Replacement Intrathecal or Epidural Drug Infusion Device/Pump W/ or W/O Programming | $35,807 | $23,275 | — | — | 29 |
| RX-205403 | UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION | $35,496 | $35,496 | — | — | 112 |
| RX-146072 | DAUNORUBICIN 44 MG AND CYTARABINE 100 MG IN LIPOSOME IV SOLUTION | $34,410 | $34,410 | — | — | 112 |
| RX-139620 | HEMIN 350 MG INTRAVENOUS POWDER FOR SOLUTION | $34,282 | $34,282 | — | — | 109 |
| RX-188251 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION | $34,004 | $34,004 | — | — | 112 |
| RX-196290 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN | $33,714 | $33,714 | — | — | 32 |
| RX-210391 | IMETELSTAT 188 MG INTRAVENOUS SOLUTION | $31,931 | $31,931 | — | — | 109 |
| RX-146231 | GEMTUZUMAB OZOGAMICIN 4.5 MG (1 MG/ML INITIAL CONCENTRATION) IV SOLN | $31,505 | $31,505 | — | — | 96 |
| RX-126219 | VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION | $30,326 | $30,326 | — | — | 112 |
| RX-203310 | RISANKIZUMAB-RZAA 60 MG/ML INTRAVENOUS SOLUTION | $30,072 | $30,072 | — | — | 112 |
| RX-196884 | PERTUZUMAB 600 MG-TRASTUZUMAB 600 MG-HYALURONID-ZZXF/10 ML SUBCUT SOLN | $29,084 | $29,084 | — | — | 112 |
| RX-124767 | OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION | $28,351 | $28,351 | — | — | 112 |
| RX-205074 | FECAL MICROBIOTA, LIVE-JSLM 150 ML RECTAL SUSPENSION ENEMA | $28,233 | $28,233 | — | — | 112 |
| RX-205988 | ANTIHEMOPHIL RFVIII FC-VWF-XTEN,BDD-EHTL 1,000 (+/-) UNIT IV SOLUTION | $28,109 | $28,109 | — | — | 112 |
| RX-199898 | ORITAVANCIN 1,200 MG INTRAVENOUS SOLUTION | $28,019 | $28,019 | — | — | 112 |
| RX-196642 | LURBINECTEDIN 4 MG INTRAVENOUS SOLUTION | $25,230 | $25,230 | — | — | 112 |
| RX-21108 | LEUPROLIDE 30 MG (4 MONTH) INTRAMUSCULAR SYRINGE KIT | $24,875 | $24,875 | — | — | 112 |
| RX-500129 | NIVOLUMAB 10 MG/ML INTRAVENOUS SOLUTION (WRAPPER) | $24,306 | $24,306 | — | — | 336 |
Showing top 50 of 3,040 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.